Your search returned 36 studies. (Get alerts for new studies):
- Combination Chemotherapy, Intensity-Modulated Radiation Therapy, and Surgery in Treating Patients With Localized Pancreatic Cancer That Can Be Removed
Conditions: Adenocarcinoma of the Pancreas - Stage IA Pancreatic Cancer - Stage IB Pancreatic Cancer - Stage IIA Pancreatic Cancer - Stage IIB Pancreatic Cancer
1 Location available
- Permission to Collect Blood Over Time for Research
Conditions: Pancreatic Cancer - Gastrointestinal Neoplasms - Colon Rectal Cancer Adenocarcinoma - Esophageal Cancer - Gall Bladder Cancer - Gastric (Stomach) Cancer - Gastrooesophageal Cancer - Gastrointestinal Stromal Tumor (GIST) - Hepatobiliary Neoplasm - Liver Ca
1 Location available
- Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas
Conditions: Metastatic Pancreatic Cancer
2 Locations available
- Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas
Conditions: Pancreatic Cancer
1 Location available
- Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma
Conditions: Pancreatic Adenocarcinoma
1 Location available
- Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer
1 Location available
- Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
Conditions: Acinar Cell Carcinoma of Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Pancreatic Carcinoma Recurrent - Stage IA Pancreatic Cancer - Stage IB Pancreatic Cancer - Stage IIA Pancreatic Cancer - Stage IIB Pancreatic Cancer - Pancreatic Carcinoma Stag
17 Locations available
- Study of Ruxolitinib in Pancreatic Cancer Patients
Conditions: Metastatic Pancreatic Adenocarcinoma
27 Locations available
- Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer
Conditions: Pancreatic Ductal Adenocarcinoma
2 Locations available
- Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
Conditions: Metastatic Pancreatic Adenocarcinoma
18 Locations available
- FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Conditions: Pancreatic Neoplasms
1 Location available
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duoden
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Pancreatic Cancer - Periampullary Adenocarcinoma - Small Intestine Cancer
2 Locations available
- GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Conditions: Adenocarcinoma of the Pancreas - Advanced Solid Tumors - Cancer - Cancer of Pancreas - Cancer of the Pancreas - Metastases - Metastatic Cancer - Metastatic Pancreatic Cancer - Pancreas Cancer - Pancreatic Cancer - Bone Metastases - Endocrine Cancer - Onco
23 Locations available
- Radiation Therapy, Tadalafil, Sargramostim, Gemcitabine, and Telomerase Vaccine (GV1001) in Patients With Pancreatic Cancer
Conditions: Locally Advanced Pancreatic Adenocarcinoma
1 Location available
- Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer
7 Locations available
- Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors or Advanced Pancreatic Ca
Conditions: Adenocarcinoma of the Pancreas - Stage III Pancreatic Cancer - Stage IV Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer
Conditions: Pancreatic Cancer - Periampullary Adenocarcinoma
1 Location available
- Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma
Conditions: Metastatic Pancreatic Adenocarcinoma
12 Locations available
- FOLFIRINOX in Patients With Inoperable Pancreatic Cancer
Conditions: Adenocarcinoma of Pancreas
1 Location available
- Feasibility and Safety Study in Patients With Metastatic Pancreatic Adenocarcinoma
Conditions: Metastatic Pancreatic Cancer
1 Location available
- Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer
1 Location available
- Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer
1 Location available
- A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer
Conditions: Advanced Adenocarcinoma - Metastatic Adenocarcinoma
1 Location available
- FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer - Adenocarcinoma - Pancreatic Neoplasms
1 Location available
- A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer
22 Locations available
- Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma
Conditions: Pancreatic Adenocarcinoma
1 Location available
- Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Safety Study of Modified Vaccinia Virus to Cancer
Conditions: Melanoma - Breast Cancer - Head and Neck Squamous Cell Cancer - Liver Cancer - Colorectal Cancer - Pancreatic Adenocarcinoma
1 Location available
- The Pancreatic Adenocarcinoma Gene Environment Risk Study - A Study of Patients at Risk or Having Pancreatic Disease
Conditions: Pancreatic Cancer
3 Locations available
- A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma
Conditions: Metastatic Pancreatic Adenocarcinoma
2 Locations available
- Stereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally
Conditions: Adenocarcinoma of the Pancreas - Pancreatic Cancer - Stage III Pancreatic Cancer
1 Location available
- Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer
3 Locations available
- Hsp90 Inhibitor STA-9090 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
1 Location available
- Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma
Conditions: Pancreas, Adenocarcinoma
2 Locations available
- Gemcitabine in Combination With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
Conditions: Resectable Pancreatic Adenocarcinoma
1 Location available
- A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.
Conditions: Metastatic Pancreatic Adenocarcinoma - Pancreatic Cancer - Metastatic Pancreatic Cancer
1 Location available
|